Biotech

All Articles

' Professional intuitiveness' led FDA consultants to back Zevra's unusual illness med

.Zevra Therapeutics' unusual disease medication seems to be to be on the course to approval this fal...

Pfizer takes $230M struck after axing failed DMD gene therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics treatment breakdown has actually blown a ...

AC Immune finds 'site' possible in Alzheimer's medication data

.After much more than twenty years of deal with neurodegenerative diseases, Swiss biotech hvac Invul...

GSK drops ph. 2 HPV vaccination over absence of best-in-class potential

.GSK has actually junked a stage 2 human papillomavirus (HPV) injection from its pipeline after maki...

OS Therapies refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.Operating system Therapies are going to specify on the NYSE American sell exchange this morning usi...

ALX's fizzling CD47 feedback fee sends out inventory spiraling down

.ALX Oncology's phase 2 stomach cancer cells feedback price has actually diminished. After observing...

Ionis axes eye ailment coming from aim ats of Roche-partnered possibility after records disappoint

.One More of Ionis Pharmaceuticals' essential midphase readouts has disappointed requirements, trigg...

Biogen's CEO claimed no unsafe handle 2023. He's ready to become bold

.While Biogen's pharma peers are looking for late-stage assets with little bit of threat, CEO Chris ...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Bio has actually been a biotech looking for a pipeline after it junked its lead possessions ...

Biogen ignores Denali Alzheimer's collab

.Biogen has restored legal rights to an early Alzheimer's ailment course to Denali Rehabs, going out...